NorthRock Partners LLC Makes New Investment in Henry Schein, Inc. (NASDAQ:HSIC)

NorthRock Partners LLC acquired a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,902 shares of the company's stock, valued at approximately $339,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HSIC. Venturi Wealth Management LLC boosted its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC grew its stake in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares during the period. Smartleaf Asset Management LLC grew its stake in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the period. Allworth Financial LP increased its holdings in shares of Henry Schein by 180.7% during the 4th quarter. Allworth Financial LP now owns 946 shares of the company's stock valued at $71,000 after purchasing an additional 609 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan acquired a new position in shares of Henry Schein in the 4th quarter valued at $95,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded down $1.05 during midday trading on Wednesday, hitting $72.08. The company had a trading volume of 2,097,786 shares, compared to its average volume of 1,648,185. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The stock has a market cap of $8.77 billion, a price-to-earnings ratio of 29.66, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business's 50-day simple moving average is $67.44 and its 200-day simple moving average is $71.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's quarterly revenue was down .1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.10 EPS. On average, research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. UBS Group decreased their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Barrington Research dropped their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Piper Sandler dropped their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Finally, StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $79.30.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.